Deciphera Pharmaceuticals (DCPH) stock is up more than 85% Tuesday and has risen 4.32% over the last 12 months. The average rating from Wall Street analysts is a Moderate Buy. Stock Score Report, InvestorsObserver’s proprietary scoring system, gives DCPH stock a score of 69 out of a possible 100.
That score is mainly influenced by a short-term technical score of 94. DCPH’s score also includes a long-term technical score of 92. The fundamental score for DCPH is 19. In addition to the average rating from Wall Street analysts, DCPH stock has a mean target price of $40.25. This means analysts expect the stock to gain 9.05% over the next 12 months.
What’s Happening with DCPH Stock Today
Deciphera Pharmaceuticals Inc (DCPH) stock is higher by 85.01% while the S&P 500 has risen 1.45% as of 10:54 AM on Tuesday, Aug 13. DCPH has risen $16.96 from the previous closing price of $19.95 on volume of 6,609,987 shares. Over the past year the S&P 500 is up 3.65% while DCPH has risen 4.32%. DCPH lost -$3.31 per share in the over the last 12 months.